Position in GERN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,712
New position
Shares Held
3,682
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#228
of 257 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026C M BIDWELL & ASSOCIATES LTD holds $723,217 across 14 Biotechnology names. GERN ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
5,255 | $368,007 | |
| 2 | INCY |
Incyte Corp
|
2,136 | $242,136 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,452 | $79,003 | |
| 4 | MNPR |
Monopar Therapeutics
|
94 | $8,703 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
64 | $5,220 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10 | $4,967 | |
| 7 | ENTA |
Enanta Pharmaceuticals Inc
|
331 | $4,825 | |
| 8 | GERN |
Geron Corp
This page
|
3,682 | $4,712 |
All Filings in GERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,712 | 3,682 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||